Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance

Molecular Metabolism - Tập 4 - Trang 310-324 - 2015
Su Gao1, Ryan P. McMillan2, Qingzhang Zhu1, Gary D. Lopaschuk3, Matthew W. Hulver2, Andrew A. Butler1,4
1Department of Metabolism and Aging, Scripps Research Institute, Jupiter, FL, USA
2Department of Human Nutrition, Foods and Exercise, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
3Department of Pediatrics, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada
4Department of Pharmacological & Physiological Science, Saint Louis University School of Medicine, Saint Louis, MO, USA

Tài liệu tham khảo

Goetze, 2014, Adropin: a new regulatory peptide in cardiovascular endocrinology, Regulatory Peptides, 190–191, 41, 10.1016/j.regpep.2014.04.002 Aydin, 2014, Three new players in energy regulation: preptin, adropin and irisin, Peptides, 56, 94, 10.1016/j.peptides.2014.03.021 Gao, 2014, Regulation of substrate oxidation preferences in muscle by the peptide hormone adropin, Diabetes, 63, 3242, 10.2337/db14-0388 Kumar, 2008, Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism, Cell Metabolism, 8, 468, 10.1016/j.cmet.2008.10.011 Wong, 2014, Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/Notch signaling pathway in mice, Journal of Biological Chemistry, 289, 25976, 10.1074/jbc.M114.576058 Lovren, 2010, Adropin is a novel regulator of endothelial function, Circulation, 122, S185, 10.1161/CIRCULATIONAHA.109.931782 Yu, 2014, Serum adropin levels are decreased in patients with acute myocardial infarction, Regulatory Peptides, 190–191, 46, 10.1016/j.regpep.2014.04.001 Yildirim, 2014, Adropin: a key component and potential gatekeeper of metabolic disturbances in policystic ovarian syndrome, Clinical and Experimental Obstetrics & Gynecology, 41, 310, 10.12891/ceog16522014 Wu, 2014, Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients, Clinical Chemistry and Laboratory Medicine: CCLM/FESCC, 52, 751, 10.1515/cclm-2013-0844 St-Onge, 2014, Fasting plasma adropin concentrations correlate with fat consumption in human females, Obesity, 22, 1056, 10.1002/oby.20631 Sayin, 2014, Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease, Journal of Pediatric Endocrinology & Metabolism: JPEM, 27, 479, 10.1515/jpem-2013-0296 Qiu, 2014, Relationship between human cord blood adropin levels and fetal growth, Peptides, 52, 19, 10.1016/j.peptides.2013.11.013 Demircelik, 2014, Adropin: a new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting, Clinical and Investigative Medicine. Medecine clinique et experimentale, 37, E338 Aydin, 2014, Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I, Peptides, 58, 91, 10.1016/j.peptides.2014.06.001 Topuz, 2013, Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus, Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, 61, 1161, 10.2310/JIM.0000000000000003 Gozal, 2013, Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function, The Journal of Pediatrics, 163, 1122, 10.1016/j.jpeds.2013.05.040 Celik, 2013, Maternal and fetal adropin levels in gestational diabetes mellitus, Journal of Perinatal Medicine, 41, 375, 10.1515/jpm-2012-0227 Celik, 2013, Deficiency of a new protein associated with cardiac syndrome X; called adropin, Cardiovascular Therapeutics, 31, 174, 10.1111/1755-5922.12025 Aydin, 2013, Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes, Molecular and Cellular Biochemistry, 380, 73, 10.1007/s11010-013-1660-4 Ganesh Kumar, 2012, Adropin deficiency is associated with increased adiposity and insulin resistance, Obesity, 20, 1394, 10.1038/oby.2012.31 Butler, 2012, Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans, The Journal of Clinical Endocrinology & Metabolism, 97, 3783, 10.1210/jc.2012-2194 Lian, 2011, Elevated plasma levels of adropin in heart failure patients, Internal Medicine, 50, 1523, 10.2169/internalmedicine.50.5163 Bremer, 2014, Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques, The Journal of Nutrition, 144, 5, 10.3945/jn.113.178061 Kuhla, 2014, Lifelong caloric restriction reprograms hepatic fat metabolism in mice, The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 69, 915, 10.1093/gerona/glt160 Partridge, 2014, The effect of dietary fat intake on hepatic gene expression in LG/J AND SM/J mice, BMC Genomics, 15, 99, 10.1186/1471-2164-15-99 McGarry, 1997, The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis, European Journal of Biochemistry, 244, 1, 10.1111/j.1432-1033.1997.00001.x Otero, 2014, Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux, The Journal of Biological Chemistry, 289, 20462, 10.1074/jbc.R114.576355 Randle, 1963, The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet, 1, 785, 10.1016/S0140-6736(63)91500-9 Hue, 2009, The Randle cycle revisited: a new head for an old hat, American Journal of Physiology. Endocrinology and Metabolism, 297, E578, 10.1152/ajpendo.00093.2009 Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, Cell Metabolism, 7, 45, 10.1016/j.cmet.2007.10.013 Muoio, 2008, Fatty acid oxidation and insulin action: when less is more, Diabetes, 57, 1455, 10.2337/db08-0281 Keung, 2013, Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice, Diabetes, 62, 711, 10.2337/db12-0259 Lusk, 1924, Animal calorimetry: twenty-fourth paper. Analysis of the oxidation of mixtures of carbohydrate and fat, Journal of Biological Chemistry, 59, 41, 10.1016/S0021-9258(18)85293-0 Araujo, 2005, Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity, Endocrinology, 146, 1428, 10.1210/en.2004-0778 Hulver, 2003 Morillas, 2001, Structural model of the catalytic core of carnitine palmitoyltransferase I and carnitine octanoyltransferase (COT): mutation of CPT I histidine 473 and alanine 381 and COT alanine 238 impairs the catalytic activity, The Journal of Biological Chemistry, 276, 45001, 10.1074/jbc.M106920200 Jing, 2013, Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation, Diabetes, 62, 3404, 10.2337/db12-1650 Welsh, 2005, Role of protein kinase B in insulin-regulated glucose uptake, Biochemical Society Transactions, 33, 346, 10.1042/BST0330346 Cho, 2001, Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta), Science, 292, 1728, 10.1126/science.292.5522.1728 Kruszynska, 2002, Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation, The Journal of Clinical Endocrinology & Metabolism, 87, 226, 10.1210/jcem.87.1.8187 Morino, 2008, Muscle-specific IRS-1 Ser→Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle, Diabetes, 57, 2644, 10.2337/db06-0454 Kramer, 2006, AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle, The Journal of Biological Chemistry, 281, 31478, 10.1016/S0021-9258(19)84060-7 Kramer, 2006, Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle, Diabetes, 55, 2067, 10.2337/db06-0150 Funai, 2013, Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling, The Journal of Clinical Investigation, 123, 1229, 10.1172/JCI65726 Zisman, 2000, Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance, Nature Medicine, 6, 924, 10.1038/78693 Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a Anai, 1999, Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats, Diabetes, 48, 158, 10.2337/diabetes.48.1.158 Hers, 2011, Akt signalling in health and disease, Cellular Signalling, 23, 1515, 10.1016/j.cellsig.2011.05.004 Holness, 2003, Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation, Biochemical Society Transactions, 31, 1143, 10.1042/bst0311143 Sugden, 2003, Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs, American Journal of Physiology - Endocrinology and Metabolism, 284, E855, 10.1152/ajpendo.00526.2002 Holness, 2000, Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding, Diabetes, 49, 775, 10.2337/diabetes.49.5.775 Lombard, 2007, Mammalian Sir2 Homolog SIRT3 regulates global mitochondrial lysine acetylation, Molecular and Cellular Biology, 27, 8807, 10.1128/MCB.01636-07 Palacios, 2009, Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle, Aging, 1, 771, 10.18632/aging.100075 Rardin, 2009, Monitoring phosphorylation of the pyruvate dehydrogenase complex, Analytical Biochemistry, 389, 157, 10.1016/j.ab.2009.03.040 Sugden, 1993, Mechanisms involved in the coordinate regulation of strategic enzymes of glucose metabolism, Advances in Enzyme Regulation, 33, 71, 10.1016/0065-2571(93)90010-B Bowker-Kinley, 1998, Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex, The Biochemical Journal, 329, 191, 10.1042/bj3290191 Lin, 2005, Metabolic control through the PGC-1 family of transcription coactivators, Cell Metabolism, 1, 361, 10.1016/j.cmet.2005.05.004 Wende, 2005, PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism, Molecular and Cellular Biology, 25, 10684, 10.1128/MCB.25.24.10684-10694.2005 Moore, 2003, Upstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Ibeta expression by PGC-1, The Journal of Biological Chemistry, 278, 17263, 10.1074/jbc.M210486200 Wende, 2007, A role for the transcriptional coactivator PGC-1α in muscle refueling, Journal of Biological Chemistry, 282, 36642, 10.1074/jbc.M707006200 Benton, 2008, Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria, The Journal of Biological Chemistry, 283, 4228, 10.1074/jbc.M704332200 Larsen, 2012, Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects, The Journal of Physiology, 590, 3349, 10.1113/jphysiol.2012.230185 Ekstrand, 2004, Mitochondrial transcription factor A regulates mtDNA copy number in mammals, Human Molecular Genetics, 13, 935, 10.1093/hmg/ddh109 Kim, 2001, Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance, Proceedings of the National Academy of Sciences of the United States of America, 98, 7522, 10.1073/pnas.121164498 Goudriaan, 2005, CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance, Journal of Lipid Research, 46, 2175, 10.1194/jlr.M500112-JLR200 Yuan, 2001, Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta, Science, 293, 1673, 10.1126/science.1061620 Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137 Boura-Halfon, 2009, Phosphorylation of IRS proteins, insulin action, and insulin resistance, American Journal of Physiology – Endocrinology and Metabolism, 296, E581, 10.1152/ajpendo.90437.2008 Yaspelkis, 2009, High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKalpha/beta phosphorylation and decreases PI-3 kinase activity in muscle, The American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 296, R1709, 10.1152/ajpregu.00117.2009 Jarriault, 1998, Delta-1 activation of notch-1 signaling results in HES-1 transactivation, Molecular and Cellular Biology, 18, 7423, 10.1128/MCB.18.12.7423 Bi, 2014, Inhibition of notch signaling promotes browning of white adipose tissue and ameliorates obesity, Nature Medicine, 20, 911, 10.1038/nm.3615 Sun, 2007, SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B, Cell Metabolism, 6, 307, 10.1016/j.cmet.2007.08.014 Pettit, 1975, Regulation of pyruvate dehydrogenase kinase and phosphatase by acetyl-CoA/CoA and NADH/NAD ratios, Biochemical and Biophysical Research Communications, 65, 575, 10.1016/S0006-291X(75)80185-9 Turner, 2007, Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents, Diabetes, 56, 2085, 10.2337/db07-0093 Crewe, 2013, Rapid inhibition of pyruvate dehydrogenase: an initiating event in high dietary fat-induced loss of metabolic flexibility in the heart, PLoS ONE, 8, e77280, 10.1371/journal.pone.0077280 Bouzakri, 2008, Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle, Diabetes, 57, 1508, 10.2337/db07-0583 Jeoung, 2008, Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice, American Journal of Physiology. Endocrinology and Metabolism, 295, E46, 10.1152/ajpendo.00536.2007 Muoio, 2012, Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility, Cell Metabolism, 15, 764, 10.1016/j.cmet.2012.04.005 Brüning, 1998, A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance, Molecular Cell, 2, 559, 10.1016/S1097-2765(00)80155-0 Palomero, 2007, Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia, Nature Medicine, 13, 1203, 10.1038/nm1636 Wong, 2012, HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRbeta-selected mouse thymocytes, Blood, 120, 1439, 10.1182/blood-2011-12-395319 Bruce, 2009, Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance, Diabetes, 58, 550, 10.2337/db08-1078 Choi, 2008, Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism, Proceedings of the National Academy of Sciences of the United States of America, 105, 19926, 10.1073/pnas.0810339105 Forstermann, 1994, Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions, Hypertension, 23, 1121, 10.1161/01.HYP.23.6.1121